← Back to Search

FOREST Program for Burnout and Secondary Traumatic Stress (FOREST Trial)

N/A

Waitlist Available

Led By Judith Moskowitz, PhD, MPH

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial program helps violence prevention workers build positive emotion skills to reduce burnout and improve resilience in their work. #mentalhealth #resilience

Who is the study for?

The FOREST trial is for frontline violence prevention workers at READI Chicago who are over 18, speak and read English, and have internet access. There are no specific exclusion criteria, so all employees meeting the inclusion conditions can participate.

What is being tested?

FOREST is a program teaching ten positive emotion skills over nine months to improve mental health and coping among participants. It's integrated into regular meetings, wellness activities, and online modules within READI's Learning Management System.

What are the potential side effects?

Since FOREST is an emotion skills program rather than a medical treatment, it does not have traditional side effects. However, participants may experience emotional discomfort or increased self-awareness as they learn new coping strategies.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Decrease in anxiety measured by PROMIS Short Form v1.0- Anxiety 4a.

Decrease in burnout measured by the Maslach Burnout Inventory (MBI).

Decrease in depression measured by PROMIS Short Form v1.0- Depression 4a.

+5 more

Secondary study objectives

Decrease in staff turnover.

Decrease in use of sick days

Increase in staff promotion

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: FOREST + AssessmentsExperimental Treatment1 Intervention

UCAN staff will participate in Monthly Skill Sessions and complete FOREST content modules in the Learning Management System (LMS). Staff will also be invited to complete annual assessments for primary and secondary outcome measures, as well as annual interviews and focus groups to gather feedback on progress, implementation, and content.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

FOREST

2021

N/A

~210

Do I qualify?Apply below to find out